| 573 |
Inhibition, cytochrome oxidase leads to Increased, pulmonary edema |
John Frisch |
BY-SA |
1840: Inhibition, cytochrome oxidase
|
2316: Increased, pulmonary edema
|
|
|
| 574 |
Inhibition, cytochrome oxidase leads to Loss of olfactory function |
John Frisch |
BY-SA |
1840: Inhibition, cytochrome oxidase
|
2317: Loss of olfactory function
|
|
|
| 639 |
Activation, estrogen receptor alpha leads to precocious puberty via increased kisspeptin release |
John Frisch |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2415: Precocious puberty
|
|
|
| 640 |
Activation, estrogen receptor alpha leads to decreased fertility via prolonged estrus cycle |
John Frisch |
BY-SA |
1065: Activation, estrogen receptor alpha
|
406: decreased, Fertility
|
|
|
| 641 |
Activation, estrogen receptor alpha leads to increased, phenotypic female-biased sex ratio via increased, differentiation to ovaries |
John Frisch |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2418: Increased, phenotypic female-biased sex ratio
|
|
|
| 623 |
Activation, estrogen receptor alpha leads to persistent vaginal cornification via increased kisspeptin release |
John Frisch |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2306: Persistent vaginal cornification
|
|
|
| 637 |
Activation, estrogen receptor alpha leads to increased uterine weight via earlier proliferation of cells of the uterine lining |
John Frisch |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2413: Increased, uterine weight
|
|
|
| 505 |
Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway |
John Frisch |
BY-SA |
1115: Increase, Reactive oxygen species
|
885: Increase, Cancer
|
|
|
| 525 |
Reduced oligodendrocyte differentiation during neurodevelopment leading to impaired learning and memory |
Ellen Fritsche |
Open for adoption |
4 MIEs
|
341: Impairment, Learning and memory
|
|
|
| 440 |
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia |
Kalyan Gayen |
BY-SA |
1046: Suppression, Estrogen receptor (ER) activity
|
2 AOs
|
Under Development |
1.104 |
| 489 |
Inhibition of voltage-gated sodium channels leading to decreased cognition |
Lidwina Gerner |
BY-SA |
1353: Binding to voltage-gated sodium channel
|
402: Cognitive function, decreased
|
|
|
| 134 |
Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Mary Gilbert |
BY-SA |
424: Inhibition, Na+/I- symporter (NIS)
|
402: Cognitive function, decreased
|
|
|
| 604 |
Binding of Alpha 1-Adrenergics to Agonists Leading to Depression |
LUANA GOMES |
All rights reserved |
2370: Agonism binding, α1-Adrenoreceptor
|
1346: Increased, depression
|
|
|
| 10 |
Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain |
Ping Gong |
BY-SA |
667: Binding at picrotoxin site, iGABAR chloride channel
|
613: Occurrence, Epileptic seizure
|
WPHA/WNT Endorsed |
1.15 |
| 270 |
Elevated ATP demand for detoxification and repair mechanisms leading to impaired locomotor activity |
Christopher Goodchild |
BY-SA |
None
|
None
|
|
|
| 269 |
Elevated ATP demand for detoxification and repair mechanisms leading to impaired growth and development |
Christopher Goodchild |
BY-SA |
None
|
None
|
|
|
| 368 |
Cytochrome oxidase inhibition leading to increased nasal lesions |
Katy Goyak |
BY-SA |
1840: Inhibition, cytochrome oxidase
|
2312: Increased, nasal lesions
|
|
|
| 7 |
Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female |
Elise Grignard |
BY-SA |
408: reduction in ovarian granulosa cells, Aromatase (Cyp19a1)
|
2 AOs
|
Under Review |
1.21 |
| 18 |
PPARα activation in utero leading to impaired fertility in males |
Elise Grignard |
BY-SA |
227: Activation, PPARα
|
2 AOs
|
Under Review |
1.21 |
| 51 |
PPARα activation leading to impaired fertility in adult male rodents |
Elise Grignard |
BY-SA |
227: Activation, PPARα
|
406: decreased, Fertility
|
Under Development |
1.21 |
| 98 |
5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation |
Ksenia Groh |
BY-SA |
619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)
|
588: Increased, predation
|
|
|
| 447 |
Kidney failure induced by inhibition of mitochondrial electron transfer chain through apoptosis, inflammation and oxidative stress pathways |
Yann GUEGUEN |
BY-SA |
None
|
759: Increased, Kidney Failure
|
|
|
| 6 |
Antagonist binding to PPARα leading to body-weight loss |
Kurt A. Gust |
BY-SA |
998: Binding of antagonist, PPAR alpha
|
864: Decreased, Body Weight
|
WPHA/WNT Endorsed |
2.3 |
| 173 |
Substance interaction with the pulmonary resident cell membrane components leading to pulmonary fibrosis |
Sabina Halappanavar |
BY-SA |
1495: Substance interaction with the lung resident cell membrane components
|
1458: Pulmonary fibrosis
|
WPHA/WNT Endorsed |
1.32 |
| 191 |
Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis |
Jonathan Haselman |
BY-SA |
1153: Inhibition, Deiodinase 3
|
1101: Altered, Amphibian metamorphosis
|
|
|